|
|
MARKETS
RECOMMENDATION:
Fresenius Kabi Oncology (Rs 66.4): Buy
We recommend a buy in the stock of Fresenius Kabi Oncology (earlier Dabur Pharma) from a short-term perspective. It is evident from the charts of the stock that the share has been on an intermediate-term uptrend from its October 2008 low of ...
RECOMMENDATION:
Day Trading Guide
...
OUTLOOK:
Investors awaiting clear trend to enter market
Inflow from overseas investors has moderated. Amid concerns over insufficient rain and a sweet aftertaste of recently announced June IIP numbers, market this week stands to be happy with moderate ups and ...
COMMENTARY:
Patni Computer hogs the limelight
HDFC Bank, ICICI Bank lose momentum. For the first time in five weeks, US stocks ended on a negative note as profit-booking set in due to a fall in consumer confidence data. The S&P-500 Index fell 0.6 per cent but still managed to end above ...
ASSET MANAGEMENT COMPANIES:
HSBC plans global funds for Indians
Hyderabad, Aug. 16 HSBC Asset Management Company is planning schemes that will invest in overseas ...
Columnists:
•
Harish Bijoor
•
Ramanujam Sridhar
•
S Ramesh Kumar
•
Radhika Chada
Comments & Letters to the Editor to: bleditor@thehindu.co.in
Subscribe to: Business Line
|
|
RSS Feeds